With his previous resistance to medical cannabis legislation, Mississippi Governor Tate Reeves is now facing considerable pressure as the House passed an amended version of the Mississippi Medical Cannabis Act by a striking 105-14 on January 19, 2022. This overwhelming bipartisan support reflects the legalization movement that began with the voter-approved Initiative 65 in November 2020. Although the state Supreme Court invalidated that initiative on a technicality in May 2021, lawmakers have continued to work on new legislation.
Legislative Momentum Builds
On the House floor, Rep. Lee Yancey articulated the urgency, stating, “We’re here because in November of 2020 there was a ballot initiative. In that ballot initiative, [68.5 percent] of the people indicated they wanted a medical marijuana program.” This sentiment underscores the strong public desire for relief options for those suffering from debilitating conditions.
Legislative Efforts and Governor’s Demands
Despite the legislature’s adjournment occurring before the Supreme Court’s ruling, Senators Kevin Blackwell and Yancey began crafting a legislative pathway to honor voter intent. Their efforts stalled when Governor Reeves declined to call a special session, despite indicating a willingness to reconsider if a compromise could be reached. Amendments proposed to address Reeves’ concerns previously met with various counter-demands.
Key Provisions of Senate Bill 2095
As the Mississippi Legislature enters its 2022 regular session, the approval of Senate Bill 2095 brings the medical cannabis initiative closer to reality. The House’s amendments have adjusted certain provisions, including lowering the allowance for dried cannabis flower from 3.5 ounces to 3 ounces per month. While maintaining a daily unit structure, the amended bill establishes a cap on the total units that can be purchased by qualifying patients.
Additionally, the new legislation includes a THC content cap of 30% on dried cannabis flowers and 60% on concentrates, while shifting oversight from the Department of Agriculture and Commerce to the Department of Health for specific regulatory functions related to the program.
Ensuring Medical Integrity
Yancey stressed that the initiative targets patients with serious medical conditions, not recreational users. He stated, “This is a medical program… This is for people with debilitating illnesses.” Current qualifying conditions for the medical cannabis program include cancer, Parkinson’s disease, and multiple sclerosis, addressing essential healthcare needs.
With the House’s revisions, the bill now awaits Senate consideration. Should it pass without further changes, it will move to Governor Reeves’ desk. Although he has previously threatened to veto the legislation based on his concerns over its provisions, both legislative chambers hold the necessary voting majority to override a veto.
Future of Medical Cannabis in Mississippi
Blackwell emphasized the legislature’s intention to accommodate the governor’s requests while ensuring that patients in need do not face delays. Yancey concluded, highlighting the stringent measures in place to ensure that the medical cannabis program serves only those who truly need it, saying, “Those are the only people I want to help.” The outcome of this legislative process could significantly shape the future landscape of medical cannabis access in Mississippi.